Fibrocell Stem-Cell Wrinkle Smoother Wins FDA Clearance
2,394 views · Published 22 June 2011 · 3:41 · Indexed 20 November 2026
Channel: Bloomberg Originals · 2011 · Entertainment
June 22 (Bloomberg) -- Fibrocell Science Inc. won U.S. approval for an injectible wrinkle treatment that uses a patient's own stem cells to restore elasticity to the skin. The Food and Drug Administration cleared azficel-T, the company said today in a statement. Fibrocell plans to sell the drug under the name LaViv. Shannon Pettypiece reports on Bloomberg Television's "Fast Forward." (Source: Bloomberg)
More from this channel
-
3:30
Market Close 6.4 - Bloomberg
-
0:17
Pens Tie Stanley Cup Series - Bloomberg
-
0:35
Hardware Price Too High - Activision - Bloomberg
-
0:31
FDIC Seeks Citigroup Shares-Up - WSJ - Bloomberg
-
0:44
Bank Have More Accounting Leeway - Bloomberg
-
0:32
Lakers Beat Magic 100-75 - Bloomberg
-
0:30
Johnson Wins 300th Game - Bloomberg
-
1:13
GM Expects To Sell Saturn To Penske Automotive - Bloomberg